A detailed history of Nebula Research & Development LLC transactions in Incyte Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 13,119 shares of INCY stock, worth $903,111. This represents 0.1% of its overall portfolio holdings.

Number of Shares
13,119
Holding current value
$903,111
% of portfolio
0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $752,112 - $900,094
13,119 New
13,119 $867 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $563,067 - $692,931
10,795 Added 198.73%
16,227 $1.02 Billion
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $313,806 - $358,131
5,432 New
5,432 $314 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.